Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 4 , Pages 254-260 , April 2011

Plasma adiponectin concentration is strongly associated with VLDL-TG catabolism in postmenopausal women

  • A. Lapointe

      Affiliations

    • Institute of Nutraceuticals and Functional Foods, Laval University, 2440 Hochelaga Blvd, Québec G1V 0A6, Canada
    • ,
  • A. Tchernof

      Affiliations

    • Molecular Endocrinology and Oncology Research Center, CHUQ, Laval University, Québec, Canada
    • ,
  • B. Lamarche

      Affiliations

    • Institute of Nutraceuticals and Functional Foods, Laval University, 2440 Hochelaga Blvd, Québec G1V 0A6, Canada
    • ,
  • M.E. Piché

      Affiliations

    • Institute of Nutraceuticals and Functional Foods, Laval University, 2440 Hochelaga Blvd, Québec G1V 0A6, Canada
    • ,
  • J. Weisnagel

      Affiliations

    • Diabetes Research Unit, CHUQ, Laval University, Québec, Canada
    • Lipid Research Center, CHUQ, Laval University, Québec, Canada
    • ,
  • J. Bergeron

      Affiliations

    • Lipid Research Center, CHUQ, Laval University, Québec, Canada
    • ,
  • S. Lemieux

      Affiliations

    • Institute of Nutraceuticals and Functional Foods, Laval University, 2440 Hochelaga Blvd, Québec G1V 0A6, Canada
    • Lipid Research Center, CHUQ, Laval University, Québec, Canada
    • Corresponding Author InformationCorresponding author. Institute of Nutraceuticals and Functional Foods, Laval University, 2440 Hochelaga Blvd, Québec G1V 0A6, Canada. Tel.: +1 418 656 2131x3637; fax: +1 418 656 5877.

Received 12 June 2009 ,Revised 16 October 2009 ,Accepted 20 October 2009.

References 

  1. Goodpaster BH, Krishnaswami S, Resnick H, Kelley DE, Haggerty C, Harris TB, et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care. 2003;26:372–379
  2. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952
  3. Bjorntorp P. “Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis. 1990;10:493–496
  4. Tremollieres FA, Pouilles JM, Cauneille C, Ribot C. Coronary heart disease risk factors and menopause: a study in 1684 French women. Atherosclerosis. 1999;142:415–423
  5. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213–219
  6. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, et al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes. 2004;53:2473–2478
  7. Ceddia RB, Somwar R, Maida A, Fang X, Bikopoulos G, Sweeney G. Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia. 2005;48:132–139
  8. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest. 2001;108:1875–1881
  9. Hung J, McQuillan BM, Thompson PL, Beilby JP. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes (Lond). 2008;
  10. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003;52:239–243
  11. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004;43:1318–1323
  12. Ng TW, Watts GF, Farvid MS, Chan DC, Barrett PH. Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics?. Diabetes. 2005;54:795–802
  13. Lohman T, Martorel R, Roche A. Standardization of anthropometric measurements. Champaign, IL: Human Kinetics; 1988;p. 39–80
  14. Ferland M, Despres JP, Tremblay A, Pinault S, Nadeau A, Moorjani S, et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr. 1989;61:139–148
  15. Piche ME, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J, Lemieux S. Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women. Diabetes. 2005;54:770–777
  16. Expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl. 1):S5–20
  17. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–E223
  18. American Heart Association. Dietary guidelines for healthy American adults. A statement for physicians and health professionals by the nutrition committee, American Heart Association. Circulation. 1988;77:721A–724A
  19. Aarsland A, Chinkes D, Wolfe RR. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J Clin Invest. 1996;98:2008–2017
  20. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res. 1982;23:1206–1223
  21. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497–509
  22. Yang LY, Kuksis A, Myher JJ, Steiner G. Origin of triacylglycerol moiety of plasma very low density lipoproteins in the rat: structural studies. J Lipid Res. 1995;36:125–136
  23. Patterson BW, Zhao G, Klein S. Improved accuracy and precision of gas chromatography/mass spectrometry measurements for metabolic tracers. Metabolism. 1998;47:706–712
  24. Myher JJ, Kuksis A. General strategies in chromatographic analysis of lipids. J Chromatogr B Biomed Appl. 1995;671:3–33
  25. Dagher FJ, Lyons JH, Finlayson DC, Shamsai J, Moore FD. Blood volume measurement: a critical study prediction of normal values: controlled measurement of sequential changes: choice of a bedside method. Adv Surg. 1965;1:69–109
  26. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006;49:755–765
  27. Tchernof A, Belanger C, Morisset AS, Richard C, Mailloux J, Laberge P, et al. Regional differences in adipose tissue metabolism in women: minor effect of obesity and body fat distribution. Diabetes. 2006;55:1353–1360
  28. Avramoglu RK, Basciano H, Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta. 2006;368:1–19
  29. von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, et al. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care. 2004;27:2925–2929
  30. Chan DC, Watts GF, Ng TW, Uchida Y, Sakai N, Yamashita S, et al. Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism. Clin Chem. 2005;51:578–585
  31. Qiao L, Zou C, van der Westhuyzen DR, Shao J. Adiponectin reduces plasma triglyceride by increasing VLDL-triglyceride catabolism. Diabetes. 2008;
  32. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8:1288–1295
  33. You M, Rogers CQ. Adiponectin: a key adipokine in alcoholic fatty liver. Exp Biol Med (Maywood). 2009;234:850–859

PII: S0939-4753(09)00253-1

doi: 10.1016/j.numecd.2009.10.007

Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 4 , Pages 254-260 , April 2011

Article Tools

* Image Usage & Resolution